-
Innovation Ranking
NewInnovation Ranking – ABN AMRO Bank NV
ABN AMRO Bank NV (ABN AMRO) is a provider of retail, private, and corporate banking products and services. Its retail portfolio consists of a wide array of financial solutions such as mortgages, savings and deposits, consumer lending, commercial lending, credit and debit cards, payments, investments, insurance, and financial planning. Offerings under Private banking include a range of wealth management solutions such as specialized services, basic banking services, integrated financial advisory, and investment solutions. The corporate banking portfolio comprises products such...
-
Product Insights
Abn Mine
The Abn Mine is a coal mine in Indonesia. It is currently in operation. Empower your strategies with our Abn Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Carcinomas Drug Details: ABN-401 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Sarcomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Sarcomas Drug Details: ABN-401 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Gastric Cancer Drug Details: ABN-401 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Metastatic Melanoma Drug Details: ABN-401 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Metastatic Breast Cancer Drug Details: ABN-401 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Metastatic Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Metastatic Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Metastatic Prostate Cancer Drug Details: ABN-401 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABN-401 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABN-401 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABN-401 in Non-Small Cell Lung Cancer Drug Details: ABN-401 is...
-
Company Insights
Innovation and Patenting activity of ABN AMRO Bank NV Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ABN AMRO Bank NV Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...